LPTX logo

Leap Therapeutics Stock Price

Symbol: NasdaqCM:LPTXMarket Cap: US$13.5mCategory: Pharmaceuticals & Biotech

LPTX Share Price Performance

US$0.32
-1.88 (-85.65%)
US$0.32
-1.88 (-85.65%)
Price US$0.32

LPTX Community Narratives

There are no narratives available yet.

Recent LPTX News & Updates

No updates

Leap Therapeutics, Inc. Key Details

US$0

Revenue

US$0

Cost of Revenue

US$0

Gross Profit

US$69.6m

Other Expenses

-US$69.6m

Earnings

Last Reported Earnings
Mar 31, 2025
Next Reporting Earnings
n/a
Earnings per share (EPS)
-1.68
Gross Margin
0%
Net Profit Margin
0%
Debt/Equity Ratio
0%

Leap Therapeutics, Inc. Competitors

 
 
 
 
 
 
 
 
 
 
 
 

About LPTX

Founded
2011
Employees
26
CEO
Douglas Onsi
WebsiteView website
www.leaptx.com

Leap Therapeutics, Inc., a biopharmaceutical company, acquires and develops antibody therapies for the treatment of cancer. Its lead clinical stage drug candidate includes DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1, which is in various ongoing clinical trials for treating esophagogastric and gynecologic cancers, and colorectal cancer. The company also develops FL-501, a monoclonal antibody that inhibits GDF-15 protein that is in preclinical trial. It has an option and license agreement with Adimab, LLC and BeiGene, Ltd. to develop and commercialize DKN-01 in Asia (excluding Japan), Australia, and New Zealand. The company was formerly known as HealthCare Pharmaceuticals, Inc. and changed its name to Leap Therapeutics, Inc. in November 2015. Leap Therapeutics, Inc. was incorporated in 2011 and is based in Cambridge, Massachusetts.

U.S. Market Performance

  • 7 Days: -0.2%
  • 3 Months: 12.2%
  • 1 Year: 22.4%
  • Year to Date: 7.7%
The Communication Services sector gained 3.4% while the market remained flat over the last week. More promisingly, the market is up 22% over the past year. Looking forward, earnings are forecast to grow by 15% annually. Market details ›
This week, we are weighing up the potential productivity gains vs job losses and economic disruption that the global economy could face over the next decade and beyond.
Continue reading